A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil

The prognostic value of tumoural epidermal growth factor receptor (EGFR), p53, thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) was analysed on 82 advanced head and neck cancer patients (71 men, 11 women; mean age 59). Induction treatment was cisplatin–5-FU ± folinic acid (61 pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Etienne, M C, Pivot, X, Formento, J L, Bensadoun, R J, Formento, P, Dassonville, O, Francoual, M, Poissonnet, G, Fontana, X, Schneider, M, Demard, F, Milano, G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362780/
https://www.ncbi.nlm.nih.gov/pubmed/10206306
http://dx.doi.org/10.1038/sj.bjc.6690297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362780/
https://www.ncbi.nlm.nih.gov/pubmed/10206306
http://dx.doi.org/10.1038/sj.bjc.6690297

Ejemplares similares